Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)

Market Cap	824.70M -12.4%
Revenue (ttm)	948.83M -6.0%
Net Income	94.89M +53.1%
EPS	0.07 +14.6%
Shares Out	n/a
PE Ratio	12.09
Forward PE	7.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	0.8350
Previous Close	0.8350
Day's Range	0.8300 - 0.8570
52-Week Range	0.6850 - 1.0800
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About Genomma Lab Internacional

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,801
• Stock Exchange: OTCMKTS
• Ticker Symbol: GNMLF

Financial Performance

In 2025, Genomma Lab Internacional's revenue was 17.54 billion, a decrease of -5.73% compared to the previous year's 18.61 billion. Earnings were 1.61 billion, an increase of 8.10%.

Financial numbers in MXN

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error